Cargando…
Cyclic Peptide-Based Biologics Regulating HGF-MET
Using a random non-standard peptide integrated discovery system, we obtained cyclic peptides that bind to hepatocyte growth factor (HGF) or mesenchymal-epithelial transition factor. (MET) HGF-inhibitory peptide-8 (HiP-8) selectively bound to two-chain active HGF, but not to single-chain precursor HG...
Autores principales: | Sato, Hiroki, Imamura, Ryu, Suga, Hiroaki, Matsumoto, Kunio, Sakai, Katsuya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662982/ https://www.ncbi.nlm.nih.gov/pubmed/33121208 http://dx.doi.org/10.3390/ijms21217977 |
Ejemplares similares
-
MET Activation by a Macrocyclic Peptide Agonist that Couples to Biological Responses Differently from HGF in a Context-Dependent Manner
por: Miao, Wenyu, et al.
Publicado: (2018) -
Dimer Interface in Natural Variant NK1 Is Dispensable for HGF-Dependent Met Receptor Activation
por: Tahira, Yumiko, et al.
Publicado: (2021) -
HGF–Met Pathway in Regeneration and Drug Discovery
por: Matsumoto, Kunio, et al.
Publicado: (2014) -
Different growth and metastatic phenotypes associated with a cell-intrinsic change of Met in metastatic melanoma
por: Adachi, Eri, et al.
Publicado: (2016) -
Artificial human Met agonists based on macrocycle scaffolds
por: Ito, Kenichiro, et al.
Publicado: (2015)